Health In Tech, Inc. Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs
Health In Tech, Inc. (HIT) had Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs of $1.42 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross › Deferred Tax Liabilities, Deferred Expense
us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts · last filed 2026-08-13
- 2026-06-30: Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs $1.42M.
- 2026-03-31: Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs $1.29M.
- 2025-12-31: Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs $1.30M.
- 2025-09-30: Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs $444.30K.
| Period end | Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs |
|---|---|
| 2026-06-30 | $1.42M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.29M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.30M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $444.30K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $427.48K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $404.69K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $376.26K 10-K · filed 2026-03-25 |
| 2023-12-31 | $359.90K 10-K · filed 2025-03-17 |